Masimo Obtains CE Mark for SEDLine, Launches EEG-Based Brain Function Monitors in European Market

Wed, 08/24/2011 - 4:51am

IRVINE, Calif., Aug. 24, 2011 /PRNewswire/ -- Masimo (NASDAQ: MASI) announced today that it has received CE Mark for its SEDLine brain function monitor — expanding  access to and availability of SEDLine's advanced neuromonitoring technology to hospitals and clinicians across Europe.  The only brain function monitor with four separate EEG channels in a single integrated algorithm SEDLine represents a critical advancement for the practice of anesthesia in Europe — more complete data for a more complete picture of brain function and sedation.    

SEDLine expands the scope of real-time data and improves the management of an anesthetic case by enabling more individualized titration.  Four channels of high-quality EEG data provide information about both sides of the brain to facilitate immediate detection of asymmetrical activity and yields a single sophisticated algorithm to give accurate, reliable information about a patient's response to anesthesia.  Masimo's SEDLine Patient State Index (PSI™), a calculated measure of brain activity that reflects the patient's current level of sedation/anesthesia(1), provides additional data to enhance anesthetic control and facilitate rapid assessment.  With demonstrated reliability under challenging clinical conditions and superior resistance to cautery(2), SEDLine offers a cost-effective solution for brain function monitoring that helps clinicians achieve targeted sedation throughout all phases of anesthesia — in the OR and ICU.


According to Michael Ramsay, M.D., Chief of Anesthesiology and Pain Management & President of the Research Institute at Baylor University Medical Center in Dallas, Texas





Share this Story

You may login with either your assigned username or your e-mail address.
The password field is case sensitive.